Special Issue "Prevention, Diagnosis and Treatment of Cervical Cancer"

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Obstetrics and Gynecology".

Deadline for manuscript submissions: 25 August 2023 | Viewed by 163

Special Issue Editors

Department of Women’s, Child and Adolescent Health, Medicine School, Federal University of Ceara, Fortaleza, Brazil
Interests: cervical cancer screening; HPV cervical cancer; HPV cervical cancer vaccine; colposcopy; HPV test; cytology
Departamento de Toco-Ginecologia, Medicine School, Federal University of Rio Grande do Norte, Natal, Brazil
Interests: cervical cancer screening; HPV cervical cancer; HPV cervical cancer vaccine; colposcopy; cancer treatment

Special Issue Information

Dear Colleagues,

Cervical cancer, caused by an invasive tumor that affects 500,000 women globally each year, is associated with the human papillomavirus (HPV). About 80% of cervical cancer cases occur among women in developing countries. Intriguingly, HPV can cause a pre-invasive lesion, allowing for both primary (vaccines) and secondary (papanicolaou, DNA HPV test) prevention measures to be taken. Screening strategies, triage for colposcopy, and the histopathological diagnosis of lesions are constantly changing. In contrast, in the diagnosis of cervical lesions, adjuvant tests such as immunohistochemistry are eventually required, which identify tumor markers to determine the lesion with the highest evolutionary risk. A tumor can be treated via surgery or radiotherapy, depending on its stage.

This special issue of Medicina intends to assemble research that addresses the prevention, diagnosis, and treatment of cervical cancer. Research in this area has evolved significantly thanks to improvements in our understanding of the association between the vaginal microbiome and metabolome; the applicability of fewer doses of prophylactic vaccines; the use of therapeutic vaccines; factors associated with the prognosis of the disease; and the increase in the number of studies on strategies for organized screening programs in under-resourced countries. Innovative research can usher in new therapeutic horizons in metabolome and vaccine therapy.

Dr. José Eleutério
Prof. Dr. Ana Katherine Da Silveira Gonçalves
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • uterine cervical neoplasms
  • papillomavirus infections
  • papillomavirus vaccines
  • papanicolaou test
  • human papillomavirus DNA tests
  • colposcopy

Published Papers

This special issue is now open for submission.
Back to TopTop